HEMAB THERAPEUTICS HLDGS INC
Q2 2026 13F Holders
Symbol
COAG
CUSIP
423494103
Type
Equity
Class
COM SHS
Num filings
56
Total reported value, excl. options
$1.33 B
Compare 2026 Q2 to
2026 Q3
Manager
Report Date
Value ($000)
Shares
Option Type